GRI Standard Comparative Table

General Disclosures

1. Organizational profile

  Disclosure Page
GRI 102: General Disclosures 2016 102-1 Name of the organization Corporate Data
102-2 Activities, brands, products, and services Corporate Data
Corporate Report 2019, page3-13
Value Creation Story
102-3 Location of headquarters Corporate Data
102-4 Location of operations Network
Group Companies
102-5 Ownership and legal form Corporate Data
102-6 Markets served Annual Securities Report
(Overview of company, Status of businesses) (Japanese only) [PDF: 903KB]
Corporate Report 2019, page3-13
Value Creation Story
102-7 Scale of the organization Corporate Data
Annual Securities Report
(Overview of company, Status of businesses) (Japanese only) [PDF: 903KB]
102-8 Information on employees and other workers Data (Labor Practices)
102-10 Significant changes to the organization and its supply chain Annual Securities Report
(Status of businesses) (Japanese only) [PDF: 903KB]
102-11 Precautionary Principle or approach Risk Management
Consumer Issues (Drug Safety / Quality Assurance)
Environmental Management
Medium-Term Environmental Action Plan
Initiatives in Energy Conservation and Global Warming Mitigation
Reduction of Waste, Effective Use of Water Resources
102-12 External initiatives United Nations Global Compact
102-13 Membership of associations Japan Business Federation (Keidanren), The Federation of Pharmaceutical Manufacturers' Association of JAPAN (F P M A J), The Japan Pharmaceutical Manufacturers Association (JPMA), etc.

2. Strategy

3. Ethics and integrity

4. Governance

GRI 102: General Disclosures 2016 102-19 Delegating authority Environmental Management (Environment & Safety Management Promotion Structure)
Risk Management (Risk Management Structure)
102-22 Composition of the highest governance body and its committees Corporate Governance Report [PDF: 777KB]
Corporate Report 2019,
page42-45 Corporate Governance,
page47-48 A Message from an Outside Director,
page49-52 Member of the Board and Corporate Auditors
102-23 Chair of the highest governance body Corporate Governance Report [PDF: 777KB]
102-24 Nominating and selecting the highest governance body Corporate Governance Policy of Mitsubishi Tanabe Pharma Corporation [PDF: 62KB]
102-25 Conflicts of interest Corporate Governance Policy of Mitsubishi Tanabe Pharma Corporation [PDF: 62KB]
Corporate Governance Report [PDF: 777KB]
102-26 Role of highest governance body in setting purpose, values, and strategy Corporate Report 2019,
page18 Message from the President : Long-term vision for our management direction,
page42-45 Corporate Governance,
page47-48 A Message from an Outside Director
102-27 Collective knowledge of highest governance body Corporate Report 2019,
page42-45 Corporate Governance,
page47-48 A Message from an Outside Director,
page49-52 Member of the Board and Corporate Auditors
102-28 Evaluating the highest governance body's performance Corporate Governance Report [PDF: 777KB]
102-29 Identifying and managing economic, environmental, and social impacts Risk Management
Environmental Management
102-30 Effectiveness of risk management processes Risk Management
Environmental Management
102-31 Review of economic, environmental, and social topics Risk Management
102-33 Communicating critical concerns Risk Management
Environmental Management
102-35 Remuneration policies Corporate Governance Report [PDF: 777KB]
Corporate Report 2019,
page45 Corporate Governance : Compensation of directors and corporate auditors
102-36 Process for determining remuneration Corporate Governance Report [PDF: 777KB]
Corporate Report 2019,
page45 Corporate Governance : Compensation of directors and corporate auditors

5. Stakeholder engagement

6. Reporting practice

GRI 102: General Disclosures 2016 102-45 Entities included in the consolidated financial statements Annual Securities Report
(Business activities, Status of subsidiaries and affiliates) (Japanese only) [PDF: 903KB]
Corporate Report 2019,
page85 Corporate Data / Investor Information
102-46 Defining report content and topic Boundaries Editorial Policies
Environmental Management
102-47 List of material topics Mitsubishi Tanabe Pharma's Materiality
102-48 Restatements of information Not applicable
102-49 Changes in reporting Not applicable
102-50 Reporting period Editorial Policies
102-51 Date of most recent report Editorial Policies
102-52 Reporting cycle Editorial Policies
102-53 Contact point for questions regarding the report Editorial Policies
102-54 Claims of reporting in accordance with the GRI Standards Not applicable
102-55 GRI content index This GRI Standard Comparative Table
102-56 External assurance Independent Third-Party Assurance Report

Material topics

Management Approach

  Disclosure Page
GRI 103: Management Approach 2016 103-1 Explanation of the material topic and its Boundary Mitsubishi Tanabe Pharma's Materiality
103-2 The management approach and its components Mitsubishi Tanabe Pharma's Materiality
103-3 Evaluation of the management approach Organizational Governance
Human Rights
Labor Practices
Environment
Fair Operating Practices
Consumer Issues
Community Involvement and Development

Economic

Economic Performance

  Disclosure Page
GRI 201: Economic Performance 2016 201-1 Direct economic value generated and distributed Annual Securities Report
(Japanese only) [PDF: 903KB]
201-2 Financial implications and other risks and opportunities due to climate change Initiatives in Energy Conservation and Global Warming Mitigation
201-3 Defined benefit plan obligations and other retirement plans Annual Securities Report
(Status of accounting ) (Japanese only) [PDF: 903KB]
201-4 Financial assistance received from government Annual Securities Report
(Status of accounting ) (Japanese only) [PDF: 903KB]

Indirect Economic Impacts

GRI 203: Indirect Economic Impacts 2016 203-1 Infrastructure investments and services supported Solving Issues Related to Improving Access to Healthcare

Anti-corruption

GRI 205: Anti-corruption 2016 205-1 Operations assessed for risks related to corruption Prevention of Bribery and Corruption
205-2 Communication and training about anti-corruption policies and procedures Prevention of Bribery and Corruption
Compliance
205-3 Confirmed incidents of corruption and actions taken Not applicable

Anti-competitive Behavior

GRI 206: Anti-competitive Behavior 2016 206-1 Legal actions for anti-competitive behavior, anti-trust, and monopoly practices Not applicable

Environmental

Energy

Water

Biodiversity

GRI 304: Biodiversity 2016 304-3 Habitats protected or restored Initiatives for the Preservation of Biodiversity

Emissions

Effluents and Waste

Environmental Compliance

GRI 307: Environmental Compliance 2016 307-1 Non-compliance with environmental laws and regulations Environmental Management (tatus of Environmental Accidents/ Violations of Environmental Laws and Regulations)

Social

Employment

  Disclosure Page
GRI 401: Employment 2016 401-1 New employee hires and employee turnover Data (Labor Practices)
401-3 Parental leave Promoting Diversity (Initiatives to Reform Working Styles)
Data (Labor Practices)

Occupational Health and Safety

GRI 403: Occupational Health and Safety 2018 403-1 Occupational health and safety management system Occupational Health and Safety
403-2 Hazard identification, risk assessment, and incident investigation Occupational Health and Safety
403-3 Occupational health services Occupational Health and Safety
403-4 Worker participation, consultation, and communication on occupational health and safety Occupational Health and Safety
403-5 Worker training on occupational health and safety Occupational Health and Safety
403-6 Promotion of worker health Occupational Health and Safety
403-7 Prevention and mitigation of occupational health and safety impacts directly linked by business relationships Occupational Health and Safety
403-8 Workers covered by an occupational health and safety management system Data (Labor Practices)
403-9 Work-related injuries Occupational Health and Safety
403-10 Work-related ill health Occupational Health and Safety
Data (Labor Practices)

Training and Education

GRI 404: Training and Education 2016 404-1 Average hours of training per year per employee Human Resources Development
404-2 Programs for upgrading employee skills and transition assistance programs Human Resources Development

Diversity and Equal Opportunity

GRI 405: Diversity and Equal Opportunity 2016 405-1 Diversity of governance bodies and employees Data

Rights of Indigenous Peoples

GRI 411: Rights of Indigenous Peoples 2016 411-1 Incidents of violations involving rights of indigenous peoples Not applicable

Human Rights Assessment

GRI 412: Human Rights Assessment 2016 412-2 Employee training on human rights policies or procedures Initiatives to Raise Human Rights Awareness

Local Communities

GRI 413: Local Communities 2016 413-1 Operations with local community engagement, impact assessments, and development programs Promotion of Local Communities (Historical Museum, Doshomachi Museum Street, The Doshomachi Club, etc.)

Customer Health and Safety

GRI 416: Customer Health and Safety 2016 416-1 Assessment of the health and safety impacts of product and service categories Consumer Issues

Marketing and Labeling

GRI 417: Marketing and Labeling 2016 417-1 Requirements for product and service information and labeling Consumer Issues (Information Provision)